Manufacturer profileAutobio Diagnostics Co., Ltd.
TaiwanChina4 products registeredFeb 22, 2024 – Apr 02, 2024
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Total products
4
Product types
4
Active products
Apr 2024
Latest registration
Company details
- Address
- No. 199, 15th Ave, National Eco & Tech Zone, 450016 Zhengzhou, China
Regulatory footprint
Search Autobio Diagnostics Co., Ltd. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"Antu" Bixi Series Blood Cultivation Base (Bactericidal)
Registered: Apr 02, 2024 • Expires: Apr 02, 2029
- Risk Class
- Class 1
- AR
- DiaTech Technology Co., Ltd.
"Antu" Intensive Medium (Sterilized)
Registered: Mar 01, 2024 • Expires: Mar 01, 2029
- Risk Class
- Class 1
- AR
- DiaTech Technology Co., Ltd.
"Antu" Identification Medium (Sterilized)
Registered: Mar 01, 2024 • Expires: Mar 01, 2029
- Risk Class
- Class 1
- AR
- DiaTech Technology Co., Ltd.
"Antu" selective medium (sterilized)
Registered: Feb 22, 2024 • Expires: Feb 22, 2029
- Risk Class
- Class 1
- AR
- DiaTech Technology Co., Ltd.
About this profile
Explore comprehensive manufacturer profile for Autobio Diagnostics Co., Ltd. based in China through Pure Global AI's free Taiwan medical device database. This manufacturer has 4 products registered in Taiwan across 4 unique product categories. Their regulatory history spans from Feb 22, 2024 to Apr 02, 2024.
This page provides detailed insights including 4 recent product registrations, 4 most popular products with "Antu" Bixi Series Blood Cultivation Base (Bactericidal) having 1 registrations, and 1 authorized representatives including DiaTech Technology Co., Ltd.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.